Correction: MDM2 E3 ligase activity is essential for p53 regulation and cell cycle integrity

Correction: MDM2 E3 ligase activity is essential for p53 regulation and cell cycle integrity

Show other versions (1)

Bibliographic Details
Main Authors:	Meenalakshmi Chinnam, Chao Xu, Rati Lama, Xiaojing Zhang, Carlos D. Cedeno, Yanqing Wang, Aimee B. Stablewski, David W. Goodrich, Xinjiang Wang
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2022-06-01
Series:	PLoS Genetics
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9236258/?tool=EBI

Similar Items

Correction: MDM2 E3 ligase activity is essential for p53 regulation and cell cycle integrity.
by: Meenalakshmi Chinnam, et al.
Published: (2022-06-01)

Dual Targeting of MDM4 and FTH1 by MMRi71 for Induced Protein Degradation and p53-Independent Apoptosis in Leukemia Cells
by: Rati Lama, et al.
Published: (2022-11-01)

The p53–Mdm2 interaction and the E3 ligase activity of Mdm2/Mdm4 are conserved from lampreys to humans
by: Venkatesh, Byrappa, et al.
Published: (2016)

Tau protein binds to the P53 E3 ubiquitin ligase MDM2
by: Martina Sola, et al.
Published: (2023-06-01)

MDM2 Inhibits Axin-Induced p53 Activation Independently of its E3 Ligase Activity.
by: Ying He, et al.
Published: (2013-01-01)

Small molecule MMRi62 targets MDM4 for degradation and induces leukemic cell apoptosis regardless of p53 status
by: Rati Lama, et al.
Published: (2022-08-01)

Detection of P53 and Mdm2 in vitiligo
by: Viroj Wiwanitkit
Published: (2013-01-01)

The Thoc1 encoded ribonucleoprotein is a substrate for the NEDD4-1 E3 ubiquitin protein ligase.
by: Fei Song, et al.
Published: (2013-01-01)

Controlling the Mdm2-Mdmx-p53 Circuit
by: David L. Waning, et al.
Published: (2010-05-01)

Molecular mechanism of CCDC106 regulating the p53-Mdm2/MdmX signaling axis
by: Ting Zhou, et al.
Published: (2023-12-01)

Modulators of the p53-MDM2 interaction : search for MDM2 interactors using structural guidance
by: Lin, Jianqing
Published: (2014)

The dual interactions of p53 with MDM2 and p300 : implications for the design of MDM2 inhibitors
by: Kannan, Srinivasaraghavan, et al.
Published: (2020)

Mdm2 and mdmX prevent ASPP1 and ASPP2 from stimulating p53 without targeting p53 for degradation.
by: Bergamaschi, D, et al.
Published: (2005)

Correction: Molecular Mechanism of Mutant p53 Stabilization: The Role of HSP70 and MDM2
Published: (2013-01-01)

ZFP14 Regulates Cancer Cell Growth and Migration by Modulating p53 Protein Stability as Part of the MDM2 E3 Ubiquitin Ligase Complex
by: Shakur Mohibi, et al.
Published: (2022-10-01)

Targeting the MDM2-p53 pathway in dedifferentiated liposarcoma
by: Raymond S. Traweek, et al.
Published: (2022-11-01)

Small Molecule Inhibitors of MDM2-p53 and MDMX-p53 Interactions as New Cancer Therapeutics
by: Yujun Zhao, et al.
Published: (2013-07-01)

PROTAC degraders with ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective
by: Xin Han, et al.
Published: (2022-05-01)

Small Molecule Modulators of RING-Type E3 Ligases: MDM and Cullin Families as Targets
by: Emil Bulatov, et al.
Published: (2018-05-01)

p53 ubiquitination by Mdm2: a never ending tail?
by: Coutts, A, et al.
Published: (2009)

Mdm2 targets the p53 transcription cofactor JMY for degradation.
by: Coutts, A, et al.
Published: (2007)

Kinetic and thermodynamic effects of phosphorylation on p53 binding to MDM2
by: Yadahalli, Shilpa, et al.
Published: (2019)

Synthesis of Amino Acids Bearing Halodifluoromethyl Moieties and Their Application to p53-Derived Peptides Binding to Mdm2/Mdm4
by: Vaas S, et al.
Published: (2023-04-01)

Targeting p53–MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials
by: Haohao Zhu, et al.
Published: (2022-07-01)

Natural products targeting the p53-MDM2 pathway and mutant p53: Recent advances and implications in cancer medicine
by: Jiang-Jiang Qin, et al.
Published: (2018-09-01)

MDM2 and MDMX bind and stabilize the p53-related protein p73
by: Ongkeko, W, et al.
Published: (1999)

The Janus Face of p53-Targeting Ubiquitin Ligases
by: Qian Hao, et al.
Published: (2020-07-01)

A chromatin-associated and transcriptionally inactive p53-Mdm2 complex occurs in mdm2 SNP309 homozygous cells.
by: Arva, N, et al.
Published: (2005)

Mdm2 inhibits the apoptotic function of p53 mainly by targeting it for degradation.
by: Yap, D, et al.
Published: (2000)

RB regulates the stability and the apoptotic function of p53 via MDM2.
by: Hsieh, J, et al.
Published: (1999)

Molecular and Biochemical Techniques for Deciphering p53-MDM2 Regulatory Mechanisms
by: Konstantinos Karakostis, et al.
Published: (2020-12-01)

On the mechanism of action of SJ-172550 in inhibiting the interaction of MDM4 and p53.
by: Michal Bista, et al.
Published: (2012-01-01)

Mdm2/p53 levels in bone marrow mesenchymal stromal cells are essential for maintaining the hematopoietic niche in response to DNA damage
by: Rasoul Pourebrahim, et al.
Published: (2023-06-01)

MDM2-BCL-XL PROTACs enable degradation of BCL-XL and stabilization of p53
by: Mengyang Chang, et al.
Published: (2022-08-01)

p21WAF1/CIP1 and MDM2 expression in non-Hodgkin's lymphoma and their relationship to p53 status: a p53+, MDM2-, p21-immunophenotype associated with missense p53 mutations.
by: Villuendas, R, et al.
Published: (1997)

Targeting Post-Translational Regulation of p53 in Colorectal Cancer by Exploiting Vulnerabilities in the p53-MDM2 Axis
by: Chunwei W. Lai, et al.
Published: (2022-01-01)

mdm2: a bridge over the two tumour suppressors, p53 and Rb.
by: Yap, D, et al.
Published: (1999)

MDM2 is a central node in the p53 pathway: 12 years and counting.
by: Bond, G, et al.
Published: (2005)

Therapeutics Targeting p53-MDM2 Interaction to Induce Cancer Cell Death
by: Nayeong Koo, et al.
Published: (2022-04-01)

The SWIB/MDM2 motif of UBE4B activates the p53 pathway
by: H. Helena Wu, et al.
Published: (2023-03-01)